Lynne N. Ward, Director at Merit Medical Systems (MMSI), executed an open-market sale of 5,000 shares valued at approximately $313,000, as disclosed in an SEC Form 4 filing. This transaction reduced her direct holdings by 39%, leaving her with 7,809 shares. Notably, this is Ward’s only open-market sale in the past year, indicating a significant reduction in her position.
This sale occurred amid declining stock performance, with shares hitting a 52-week low shortly after the transaction, attributed to broader macroeconomic concerns, including rising tariffs and decelerating growth. Merit Medical’s guidance for 2026, projecting $1.6 billion in sales, reflects only a modest increase from the previous year, raising investor apprehensions about future performance.
For market professionals, Ward’s continued ownership of 7,809 shares suggests she maintains confidence in Merit Medical’s long-term prospects, despite recent challenges. This could indicate a potential buying opportunity for investors looking to capitalize on the stock’s recovery as macroeconomic conditions improve.
Source: fool.com